Since the pandemic, the US Food and Drug Administration’s Expanded Access pathway has been featured in headlines as a mechanism by which unapproved but potentially beneficial treatments were given to patients outside of randomized clinical trials.
With today’s well-known workforce challenges, it is more important than ever for sites to address workforce development in a meaningful way, reimagining the way clinical research department performs in an organizational context.
The Association of Clinical Research Professionals (ACRP) today announces Duke Office of Clinical Research, HCA Healthcare Research Institute, and Florence Healthcare as the newest members of ACRP’s Partners Advancing the Clinical Research Workforce™.
Dr. Christine Senn, Chair of the ACRP Board of Trustees, shares her outlook on the current state of the Association and the clinical research enterprise.
Improving racial and ethnic diversity of clinical trial participants is essential for generalizable, quality clinical research results and ensuring social and medical equity.
